Josh Lehrer, M.D., M.Phil., FACC
Equibles does not estimate personal net worth.
Get an email with a short summary when Lisata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LSTA alertsAbout Josh Lehrer, M.D., M.Phil., FACC
Josh Lehrer, M.D., M.Phil., FACC is recorded as COO at Lisata Therapeutics, Inc. (LSTA) since September 17, 2026. Lisata Therapeutics, Inc. reported in an 8-K filed September 17, 2026 that Josh Lehrer, M.D., M.Phil., FACC was appointed President and Chief Operating Officer, effective September 17, 2026. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), David J. Mazzo, Ph.D. (CEO), Gregory Brown (Chairman) and 7 others.
“In accordance with the Merger Agreement, on September 17, 2026, effective immediately after the First Effective Time, Josh Lehrer, M.D., M.Phil., FACC was appointed as the President and Chief Operating Officer of the Company.”
Affiliation history
-
Current
2026-09-17–present
Company network
Leadership on record at Lisata Therapeutics, Inc.
- David J. Mazzo CEO, Board Member
- David J. Mazzo, Ph.D. CEO
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member
- CLASS I Board Member